One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Aspirin Prophylaxis for Preeclampsia Prevention in Nigeria: An Explanatory Sequential Mixed Methods Study
Understanding Why Aspirin Is Underutilized for Hypertensive Disorders of Pregnancy: Lessons Learned in Nigeria
Prevalence, Awareness, and Treatment of Hypertension in 37 African Countries: Trends From 2003 to 2022
Addressing Sub-Saharan Africa’s Hypertension Care Crisis Through a Data-Driven Approach
Association of Lp(a) With Cardiovascular Disease and All-Cause Mortality in U.S. Hispanics and Latinos
Gearing Up for Lipoprotein(a) Screening and Management: Distributions and Risk in the Hispanic/Latino Population
Pulsed Field Ablation Using a Novel Biphasic Catheter vs Thermal Ablation for Paroxysmal Atrial Fibrillation: InsightPFA Trial
Pulse Field Ablation for Atrial Fibrillation: How Doers Get More Done?
Twice-Daily Clopidogrel vs Ticagrelor to Reduce Short-Term Major Adverse Cardiovascular Events After Primary Percutaneous Coronary Intervention: The TADCLOT Trial
Informative Insights From an Inconclusive Trial About Dual Antiplatelet Therapy
A Tad Bit of Extra Clarity About Clots: Why JACC Took Interest in TADCLOT
Personalized or Standard Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: The PARTHENOPE Randomized Trial
A Randomized Trial Evaluating the DAPT Score in Clinical Practice: The Ultimate Validation?
How PARTHENOPE Charts the Course Toward Precision DAPT: Navigating Future Science in Antiplatelet Therapy
Lessons Learned From Treating 34 Million People With Hypertension: The Global HEARTS Initiative
Global Development Assistance for Health Allocated to Cardiovascular Disease Control, 2015 to 2022
Nationwide Trends in Coronary Revascularization in Japan, 2017 to 2023: From Decline to Plateau
Evaluation of the PREVENT Equations in a Nationwide Cohort of 7.7 Million Korean Adults
